These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 6102137)

  • 21. [Comparative anorexigenic activity and other pharmacological properties of quipazine and its N-acyl derivatives].
    Trubitsyna TK; Asnina VV; Mashkovskiĭ MD
    Farmakol Toksikol; 1986; 49(1):44-9. PubMed ID: 3948987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of quipazine on blood pressure in pithed rats.
    Shin YK; Svinareff P; Schmitt-Jubeau H; Schmitt H
    Arch Int Pharmacodyn Ther; 1983 Jul; 264(1):73-81. PubMed ID: 6138006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional consequences of inhibiting serotonin uptake with fluoxetine in rats.
    Fuller RW
    Adv Biochem Psychopharmacol; 1982; 34():219-28. PubMed ID: 6753512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modification of drug-induced catatonia and tremors by quapazine in rats and mice.
    Kulkarni SK; Arzi A; Kaul PN
    Jpn J Pharmacol; 1980 Apr; 30(2):129-35. PubMed ID: 7192759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specificity of serotoninergic involvement in the decrease of food intake induced by quipazine in the rat.
    Samanin R; Bendotti C; Candelaresi G; Garattini S
    Life Sci; 1977 Nov; 21(9):1259-66. PubMed ID: 270605
    [No Abstract]   [Full Text] [Related]  

  • 26. The inability of chronic fluoxetine to potentiate a serotonin mediated effect.
    Sugrue MF
    Commun Psychopharmacol; 1980; 4(2):131-4. PubMed ID: 6968660
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of quipazine and D-fenfluramine, two serotonin-like drugs, on TSH secretion in basal and cold stimulated conditions in the rat.
    Di Renzo GF; Quattrone A; Schettini G; Preziosi P
    Life Sci; 1978 Jun; 22(21):1879-85. PubMed ID: 672433
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of fluoxetine on warfarin metabolism in the rat and man.
    Rowe H; Carmichael R; Lemberger L
    Life Sci; 1978 Aug; 23(8):807-11. PubMed ID: 309056
    [No Abstract]   [Full Text] [Related]  

  • 29. Biochemical effects of quipazine on rat striatal dopaminergic system.
    Ponzio F; Consolazione A; Calderini G; Achilli G; Rocchetti M; Algeri S
    Life Sci; 1981 Jul; 29(1):83-91. PubMed ID: 7266263
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of quipazine and LSD on monoamines in the rat striatum.
    Miśkiewicz M; Rokosz-Pelc A; Vetulani J
    Pol J Pharmacol Pharm; 1979; 31(5):489-92. PubMed ID: 94944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chlordiazepoxide-fluoxetine interactions on food intake in free-feeding rats.
    Feldman RS; Smith WC
    Pharmacol Biochem Behav; 1978 Jun; 8(6):749-52. PubMed ID: 308664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blockade of 5-hydroxytryptamine (5-HT) receptors by quipazine [proceedings].
    Lansdown MR; Nash HL; Preston PR; Wallis DI
    Br J Pharmacol; 1979 May; 66(1):80P-81P. PubMed ID: 454965
    [No Abstract]   [Full Text] [Related]  

  • 33. [Quipazine antagonizing baclofen activity. Influence of baclofen and gamma-hydroxybutyric acid on serotonin metabolism in rat brain (author's transl)].
    Waldmeier PC; Maître L
    Arzneimittelforschung; 1978; 28(9):1507-8. PubMed ID: 582544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5-Hydroxytryptamine-like properties of m-chlorophenylpiperazine: comparison with quipazine.
    Rokosz-Pelc A; Antkiewicz-Michaluk L; Vetulani J
    J Pharm Pharmacol; 1980 Mar; 32(3):220-2. PubMed ID: 6103943
    [No Abstract]   [Full Text] [Related]  

  • 35. Quipazine and induction of adrenal enzymes.
    Ekker M; Missala K; Sourkes TL
    Biochem Pharmacol; 1984 May; 33(10):1687-9. PubMed ID: 6145420
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of the behavioral effects of para-chloroamphetamine, chlordimeform, quipazine, and intraventricular serotonin in the rat.
    Pfister WR; Noland V; Lowy MT; Nichols DE; Yim GK
    Commun Psychopharmacol; 1978; 2(4):287-95. PubMed ID: 729354
    [No Abstract]   [Full Text] [Related]  

  • 37. Antidepressants and the control of predatory behavior.
    Schmidt WJ; Meierl G
    Physiol Behav; 1980 Jul; 25(1):17-9. PubMed ID: 6968075
    [No Abstract]   [Full Text] [Related]  

  • 38. Fluoxetine, pharmacology and physiologic disposition.
    Lemberger L; Farid NA; Bergstrom RF; Wolen RL
    Int J Obes; 1987; 11 Suppl 3():157-61. PubMed ID: 3501991
    [No Abstract]   [Full Text] [Related]  

  • 39. On the role of the central serotoninergic system in the regulation of the secretion of thyrotropin and prolactin: thyrotropin-inhibiting and prolactin-releasing effects of 5-hydroxytryptamine and quipazine in the male rat.
    Krulich L; Vijayan E; Coppings RJ; Giachetti A; McCann SM; Mayfield MA
    Endocrinology; 1979 Jul; 105(1):276-83. PubMed ID: 446410
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of midbrain raphe lesion or 5,7-dihydroxytryptamine treatment on the prolactin-releasing action of quipazine and D-fenfluramine in rats.
    Quattrone A; Schettini G; di Renzo G; Tedeschi G; Preziosi P
    Brain Res; 1979 Sep; 174(1):71-9. PubMed ID: 487124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.